Dr. Rajni Agarwal, MD
Claim this profileLucile Packard Children's Hospital
Studies Fanconi Syndrome
Studies Fanconi Anemia
4 reported clinical trials
7 drugs studied
Area of expertise
1Fanconi Syndrome
FANCA positive
FANCC positive
FANCG positive
2Fanconi Anemia
FANCA positive
FANCC positive
FANCG positive
Affiliated Hospitals
Clinical Trials Rajni Agarwal, MD is currently running
CD4^LVFOXP3
for IPEX Syndrome
This trial tests if using special immune cells can help patients with a rare immune disorder by replacing their faulty immune cells, aiming to restore immune balance and improve health.
Recruiting1 award Phase 1
Stem Cell Transplant with T-allo10 Addback
for Blood Diseases
The purpose of this study is to determine the safety of a cell therapy, T-allo10, after αβdepleted-HSCT in the hopes that it will boost the adaptive immune reconstitution of the patient while sparing the risk of developing severe Graft-versus-Host Disease (GvHD). The primary objective of Phase 1a is to determine the recommended Phase 2 dose (RP2D) administered after infusion of αβdepleted-HSCT in children and young adults with hematologic malignancies. A Phase 1b extension will occur after dose escalation, enrolling at the RP2D for the T-allo10 cells determined in the Phase 1 portion to evaluate the safety and efficacy of infusion of T-allo10 after receipt of αβdepleted-HSCT. Additionally, Phase 1b aims to explore improvements in immune reconstitution. All participants on this study must be enrolled on another study: NCT04249830
Recruiting1 award Phase 16 criteria
More about Rajni Agarwal, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Rajni Agarwal, MD has experience with
- JSP191
- Depleted Stem Cell Transplant
- T-allo10 Cells Addback
- Allogeneic Stem Cell Transplant
- CliniMACS Prodigy System
- CD4^LVFOXP3
Breakdown of trials Rajni Agarwal, MD has run
Fanconi Syndrome
Fanconi Anemia
IPEX Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rajni Agarwal, MD specialize in?
Rajni Agarwal, MD focuses on Fanconi Syndrome and Fanconi Anemia. In particular, much of their work with Fanconi Syndrome has involved FANCA positive patients, or patients who are FANCC positive.
Is Rajni Agarwal, MD currently recruiting for clinical trials?
Yes, Rajni Agarwal, MD is currently recruiting for 3 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Rajni Agarwal, MD has studied deeply?
Yes, Rajni Agarwal, MD has studied treatments such as JSP191, Depleted Stem Cell Transplant, T-allo10 cells addback.
What is the best way to schedule an appointment with Rajni Agarwal, MD?
Apply for one of the trials that Rajni Agarwal, MD is conducting.
What is the office address of Rajni Agarwal, MD?
The office of Rajni Agarwal, MD is located at: Lucile Packard Children's Hospital, Palo Alto, California 94305 United States. This is the address for their practice at the Lucile Packard Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.